Trial Profile
To evaluate the efficacy and safety of acotiamide in subjects with functional dyspepsia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 10 May 2011 Results presented at Digestive Disease Week 2011.
- 29 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.